Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (431-440 of 669) with videos related to

Pageof 67
Sort By:
Oncotarget|December 31, 2015
Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicinYi-Jun Wang, Yujian Huang, Nagaraju Anreddy, et al.
Molecular Cancer Therapeutics|September 11, 2014
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancerHua Sui, Guo-Xiang Cai, Shu-Fang Pan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 12, 2023
Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug FormulationsZhicheng Xiao, Yi Li, Liyan Xiong, et al.
Acta Biomaterialia|July 30, 2015
Exploring naturally occurring ivy nanoparticles as an alternative biomaterialYujian Huang, Yi-Jun Wang, Yongzhong Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2021
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagyXin Peng, Shaolu Zhang, Wenhui Jiao, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2021
Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagyXin Peng, Shaolu Zhang, Wenhui Jiao, et al.
Journal of Medicinal Chemistry|August 4, 2022
Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor EffectsHuajian Zhu, Yuchen Tan, Chen He, et al.
Cancer Letters|February 24, 2009
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2Chun-ling Dai, Yong-ju Liang, Yan-sheng Wang, et al.
Journal of Natural Products|June 19, 2009
Sipholane triterpenoids: chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modelingSandeep Jain, Ioana Abraham, Paulo Carvalho, et al.
International Journal of Oncology|March 15, 2014
Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistanceRishil J Kathawala, Jun-Jiang Chen, Yun-Kai Zhang, et al.
Pageof 67

Showing results (431-440 of 669) with videos related to

Sort By:
Pageof 67
Oncotarget|December 31, 2015
Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicinYi-Jun Wang, Yujian Huang, Nagaraju Anreddy, et al.
Molecular Cancer Therapeutics|September 11, 2014
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancerHua Sui, Guo-Xiang Cai, Shu-Fang Pan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 12, 2023
Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug FormulationsZhicheng Xiao, Yi Li, Liyan Xiong, et al.
Acta Biomaterialia|July 30, 2015
Exploring naturally occurring ivy nanoparticles as an alternative biomaterialYujian Huang, Yi-Jun Wang, Yongzhong Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2021
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagyXin Peng, Shaolu Zhang, Wenhui Jiao, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 21, 2021
Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagyXin Peng, Shaolu Zhang, Wenhui Jiao, et al.
Journal of Medicinal Chemistry|August 4, 2022
Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor EffectsHuajian Zhu, Yuchen Tan, Chen He, et al.
Cancer Letters|February 24, 2009
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2Chun-ling Dai, Yong-ju Liang, Yan-sheng Wang, et al.
Journal of Natural Products|June 19, 2009
Sipholane triterpenoids: chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modelingSandeep Jain, Ioana Abraham, Paulo Carvalho, et al.
International Journal of Oncology|March 15, 2014
Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistanceRishil J Kathawala, Jun-Jiang Chen, Yun-Kai Zhang, et al.
Pageof 67